Gatifloxacin and moxifloxacin: two new fluoroquinolones.
D000890:Anti-Infective Agents / Q000493:pharmacokinetics / Q000494:pharmacology* / Q000627:therapeutic use*; D001372:Aza Compounds; D017714:Community-Acquired Infections / Q000150:complications / Q000188:drug therapy; D024841:Fluoroquinolones; D005767:Gastrointestinal Diseases / Q000139:chemically induced; D000077734:Gatifloxacin; D006801:Humans; D000077266:Moxifloxacin; D011014:Pneumonia / Q000188:drug therapy* / Q000209:etiology; D011804:Quinolines; D013211:Staphylococcus aureus / Q000187:drug effects
D000890:Anti-Infective Agents; D001372:Aza Compounds; D024841:Fluoroquinolones; D011804:Quinolines; D000077734:Gatifloxacin; D000077266:Moxifloxacin